LQCL2506 - CMLE - Clinical Utility of Reporting Cytoplasmic HEp-2 IFA Patterns

Course Description

LabQ 2025 Clinical Laboratory: Clinical Immunology

Faculty/Authors

Dharmendra Jain, PhD
Lisa K Peterson, PhD, D(ABMLI)
Associate Professor, Pathology
Medical Directory, Immunology
University of Utah School of Medicine
ARUP Laboratories
Salt Lake City, Utah

CMLE Credit: 2.0
Estimated Completion Time: 2 hour
Format: Online Educational Activity and Post Exam

Instructions

To claim CMLE credit for the exercise, do the following:

Review the Technical Considerations.
Click Go to Course to view an overview of the modules in this course.
Click Access to begin the course.
Review the Educational Activity.
Complete and submit the Post Exam.
Submit the course Evaluation to register your credit.

Faculty Disclosures
The faculty have no relevant financial relationships with commercial interests to disclose.

Technical Considerations

Release Date: 5/31/2025
Review Date:
Expiration Date: 12/31/2027

Course Objectives

Following completion of this activity, you will be able to:

describe the differences that exist in nomenclature and interpretation of HEp-2 IFA antibody results;

recognize gaps in the knowledge regarding the clinical significance of cytoplasmic HEp-2 IFA staining patterns;

identify opportunities for improving HEp-2 FA nomenclature and reporting; and

discuss the role of cytoplasmic HEp-2 IFA staining associated with anti-Ribo P antibodies in the diagnosis of SLE.

Summary

Availability:

On-Demand

Credit Offered:

2 CMLE Credits